FALLICA, ANTONINO NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 429
EU - Europa 264
AS - Asia 70
AF - Africa 49
SA - Sud America 6
OC - Oceania 2
Totale 820
Nazione #
US - Stati Uniti d'America 425
IT - Italia 155
SG - Singapore 50
IE - Irlanda 43
CI - Costa d'Avorio 41
DE - Germania 23
CN - Cina 20
ES - Italia 17
RU - Federazione Russa 8
SN - Senegal 8
BR - Brasile 5
GB - Regno Unito 4
UA - Ucraina 4
CA - Canada 3
CH - Svizzera 3
AU - Australia 2
SE - Svezia 2
CL - Cile 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
LU - Lussemburgo 1
MX - Messico 1
NL - Olanda 1
Totale 820
Città #
Chandler 112
Santa Clara 97
Dublin 43
Singapore 43
Abidjan 41
Catania 34
Chicago 33
Ashburn 23
Boardman 22
Barcelona 14
Bremen 11
Cambridge 11
Civitanova Marche 11
Lawrence 11
Andover 10
Dakar 8
Redmond 6
Wilmington 5
Los Angeles 4
Moscow 4
Salerno 4
Arezzo 3
Des Moines 3
Gela 3
Nanjing 3
Padova 3
Palermo 3
Pozzallo 3
Rome 3
Santa Maria di Licodia 3
Cagliari 2
Ferrara di Monte Baldo 2
Foggia 2
Ludwigshafen 2
Madrid 2
Nanchang 2
Naples 2
São Paulo 2
Toronto 2
Atripalda 1
Augusta 1
Brno 1
Canberra 1
Corigliano Calabro 1
Dallas 1
Dongyang 1
Edinburgh 1
Esslingen am Neckar 1
Fairfield 1
Ferrara 1
Garbagnate Milanese 1
Hebei 1
Hwang Chow 1
Itaboraí 1
Jinzhong 1
Lappeenranta 1
Latina 1
Leawood 1
London 1
Luxembourg 1
Melbourne 1
Milan 1
Misterbianco 1
New York 1
Novara 1
Ottawa 1
Phoenix 1
Piazza Armerina 1
Piedimonte Etneo 1
Piemonte 1
Porto San Giorgio 1
Redwood City 1
Reggio Calabria 1
Rimini 1
Rio Grande 1
Salvador 1
Santiago 1
Seattle 1
Shenyang 1
Turin 1
Villafranca Tirrena 1
Xianyang 1
Zhengzhou 1
Totale 636
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 108
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 82
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 71
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 65
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 65
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 65
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 60
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 59
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 53
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 46
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 44
The potential role of sildenafil in cancer management through epr augmentation 37
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections 29
Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale 27
The Promise of Nanotechnology in Personalized Medicine 25
Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer 22
Totale 858
Categoria #
all - tutte 3.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 1 2 1 1
2020/202132 0 0 3 9 8 0 2 2 0 1 4 3
2021/2022130 11 8 24 3 16 2 23 10 7 5 0 21
2022/2023264 26 18 7 45 23 45 1 36 45 2 12 4
2023/2024126 4 13 4 3 12 55 1 2 3 6 13 10
2024/2025275 5 53 18 36 90 56 15 2 0 0 0 0
Totale 858